Featured Story | By Nick Paul Taylor Jim Sherblom has joined ReForm Biologics as chair to lead a new strategy. The ex-Genzyme executive arrives at ReForm as it switches focus to the development of subcutaneous versions of intravenous products. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor ScPharmaceuticals has outlined plans to submit its heart failure candidate Furoscix for FDA approval for a third time later this year. The company expects to be ready to refile once it has completed work including modified bench tests on aged commercial units of its on-body drug delivery system. read more By Nick Paul Taylor PLx Pharma has won FDA approval for its liquid-filled aspirin capsule Vazalore. The formulation has bettered enteric-coated and immediate-release aspirin in some regards in clinical trials. read more By Nick Paul Taylor Sun Pharmaceutical Industries has created a U.S. website for its long-term care (LTC) division. The site pulls together products aimed at the 40% of American adults estimated to have trouble swallowing tablets and capsules. read more By Conor Hale Eli Lilly & Co. has signed a deal to link Welldoc’s digital health platform with its upcoming connected insulin devices and therapies. read more Resources Sponsored by: AmerisourceBergen Unlock product potential by making the most of your commercialization investments. Sponsored By: Acorn AI Unlock competitive advantage with AI and advanced analytics. Sponsored By: EVERSANA Mature brands lost billions in revenue and value during COVID, but with the right strategy, pharma can rebound and reignite revenue. Learn How. Sponsored By: BC Platforms Download our whitepaper to learn how BC Platforms has leveraged our technical expertise to offer robust and comprehensive solutions to maximize RWD ROI. Sponsored By: Thermo Fisher Scientific Involved in vaccine development? Check out this timely infographic detailing the history of vaccines, key development milestones, and what challenges remain. Sponsored By: Blue Matter, strategic consultants in the life sciences A look ahead at how cell-based therapies in oncology will advance during 2021-22: research, regulatory, and commercial milestones. Sponsored By: Baxter BioPharma Solutions While service directories are filled with CMOs claiming vaccine fill-finish experience, the logistical challenges resulting from seasonal product are unique and it is important that outsourcing partners can ensure quality and on-time delivery. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. | 
